{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:36:07Z","timestamp":1794562567999,"version":"4.9.1"},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T00:00:00Z","timestamp":1197244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Haemophagocytic lymphohistiocytosis (HLH) may cause meningoencephalitis and significant neurological sequelae. We examined the relationship between neurological symptoms and cerebrospinal fluid (CSF) at diagnosis, and long\u2010term outcome, in all children enroled in the HLH\u201094\u2010study prior to July 1, 2003, for whom information on CSF at diagnosis was available (<jats:italic>n<\/jats:italic>\u2003=\u2003193). Patients were divided into four groups: (i) normal CSF (cells\/protein) and no neurological symptoms (<jats:italic>n<\/jats:italic>\u2003=\u200371); (ii) normal CSF but neurological symptoms (<jats:italic>n<\/jats:italic>\u2003=\u200321); (iii) abnormal CSF but no symptoms (<jats:italic>n<\/jats:italic>\u2003=\u200350); and (iv) abnormal CSF with neurological symptoms (<jats:italic>n<\/jats:italic>\u2003=\u200351). At diagnosis, neurological symptoms were reported in 72\/193 (37%) (seizures\u2003=\u200323); abnormal CSF in 101\/193 (52%), and either or both in 122\/193 (63%). Altogether 16\/107 (15%) survivors had neurological sequelae at follow\u2010up (median 5\u00b73\u2003years). Multivariate hazard ratios (HR) for mortality were 0\u00b798 [95% confidence interval (CI)\u2003=\u20030\u00b742\u20132\u00b731], 1\u00b752 (0\u00b782\u20132\u00b782) and 2\u00b705 (1\u00b713\u20133\u00b772) for groups 2\u20134, compared with group 1. Moreover, sequelae were more frequent in group 4 (7\/21, 33%) compared to groups 1\u20133 (9\/86, 10%) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7015). Patients with abnormal CSF at diagnosis had significantly increased mortality [HR\u2003=\u20031\u00b778 (95% CI\u2003=\u20031\u00b708\u20132\u00b792), <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7023]. Thus, a substantial proportion of HLH survivors suffer neurological sequelae, and children with abnormal CSF have increased risk of mortality and neurological sequelae. Prompt treatment of HLH at onset or relapse may reduce these complications.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06922.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T07:56:06Z","timestamp":1202284566000},"page":"327-335","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":219,"title":["Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis"],"prefix":"10.1111","volume":"140","author":[{"given":"AnnaCarin","family":"Horne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Trottestam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Maarten","family":"Egeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Filipovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Imashuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gritta","family":"Janka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u2010Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Histiocyte Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,12,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(76)90013-1"},{"key":"e_1_2_8_3_1","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis: diagnosis, treatment and prognostic factors. Report of 122 children from the international registry","volume":"10","author":"Arico M.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2003.11.013"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1030"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/318796"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1989.tb11068.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01538.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00855-9"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3590"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-003-0894-9"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.794"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91008-V"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70196-3"},{"key":"e_1_2_8_15_1","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis","volume":"18","author":"Henter J.\u2010I.","year":"1991","journal-title":"Seminars in Oncology"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1991.tb11878.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.11.2918.2918"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<21::AID-MPO5>3.0.CO;2-W"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70520-7"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0172"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05502.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05501.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10515"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00443367"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04726.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2001.tb00760.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.192.3.8058942"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.8.2128.2128"},{"key":"e_1_2_8_31_1","first-page":"2181","volume-title":"Nelson Textbook of Pediatrics","author":"Nicholson J.F.","year":"2000"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1789"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80549-1"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.5.e636"},{"key":"e_1_2_8_35_1","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial hemophagocytic lymphohistiocytosis: association with disease\u2010free remissions and hematopoietic malignancies","volume":"43","author":"Rudd E.","year":"2006","journal-title":"Journal of Medical Genetics"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0260"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi076"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1957"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06922.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06922.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:23:23Z","timestamp":1697455403000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06922.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,10]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06922.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06922.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,10]]},"assertion":[{"value":"2007-12-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}